As one of the most commonly detected viruses in CNS tumors, the JCV encoded T-antigen has been shown to inactivate p53’s tumor suppressing functions and promote cell cycle progression, while these capacities of T-antigen can be independently regulated by glucose availability or insulin signaling cascades [170–173]. The gene discussed is INS; the disease is central nervous system neoplasm.